Heterogeneity in antihypertensive treatment discontinuation between drugs belonging to the same class

Journal of Hypertension

Volumn 29, Issue 5, 2011, Pages 1012-1018

  Mancia, Giuseppe ^a,d   Parodi, Andrea ^b   Merlino, Luca ^c   Corrao, Giovanni ^b  

^a Department of Clinical Medicine and Prevention ^*  (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c Operative Unit of Territorial Health Services   (Italy)

^d SAN GERARDO HOSPITAL   (Italy)

Author keywords

antihypertensive drugs; cost benefit of treatment; treatment compliance; treatment discontinuation

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CILAZAPRIL; DELAPRIL; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; EPROSARTAN; FOSINOPRIL; IRBESARTAN; LERCANIDIPINE; LISINOPRIL; LOSARTAN; MANIDIPINE; MEPIRODIPINE; MOEXIPRIL; NICARDIPINE; NISOLDIPINE; PERINDOPRIL; QUINAPRIL; RAMIPRIL; SPIRAPRIL; TELMISARTAN; TRANDOLAPRIL; UNINDEXED DRUG; ZOFENOPRIL;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT WITHDRAWAL;

EID: 79954729214     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32834550d0     Document Type: Article

References (32)

1. Caro JJ, Speckman JL, Salas M, Raggio G, Jackson JD. Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data. CMAJ 1999; 160:41-46. (Pubitemid 29054225)
2. Degli Esposti E, Sturani A, Di Martino M, Falasca P, Novi MV, Baio G, Buda S. Long-term persistence with antihypertensive drugs in new patients. J Hum Hypertens 2002; 16:439-444. (Pubitemid 34685595)
3. Bourgault C, Séné cal M, Brisson M, Marentette MA, Gré goire JP. Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study. J Hum Hypertens 2005; 19:607-613.
4. Fitz-Simon N, Bennett K, Feely J. A review of studies of adherence with antihypertensive drugs using prescription databases. Therap Clin Risk Manag 2005; 1:93-106.
5. Mazzaglia G, Mantovani L, Sturkenboom MC, Filippi A, Trifirò G, Cricelli C, et al. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care. J Hypertens 2005; 23:2093-2100. (Pubitemid 41830406)
6. Van Wijk BLG, Klungel OH, Heerdink ER, de Boer A. Rate and determinants of 10-year persistence with antihypertensive drugs. J Hypertens 2005; 23:2101-2107. (Pubitemid 41830407)
7. Burke TA, Sturkenboom MC, Lu SE, Wentworth CE, Lin Y, Rhoads GG. Discontinuation of hypertensive drugs among newly diagnosed hypertensive patients in UK general practice. J Hypertens 2006; 24:1193-1200. (Pubitemid 43772328)
8. Elliott WJ, Plauschinat CA, Skrepnek GH, Gause D. Persistence, adherence, and risk of discontinuation associated with commonly prescribed antihypertensive drug monotherapies. J Am Board Fam Med 2007; 20:72-80. (Pubitemid 46219403)
9. Corrao G, Zambon A, Parodi A, Poluzzi E, Baldi I, Merlino L, et al. Discontinuation of and changes in drug therapy for hypertension among newly treated patients: a population-based study in Italy. J Hypertens 2008; 26:819-824. (Pubitemid 351354932)
10. Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 2008; 336:1114-1117. (Pubitemid 351731741)
11. Bramley TJ, Gerbino PP, Nightengale BS, Frech-Tamas F. Relationship of blood pressure control to adherence with antihypertensive monotherapy in .13. managed care organizations. J Manag Care Pharm 2006; 12:239-245. (Pubitemid 47400613)
12. Krousel-WoodM, Thomas S, Muntner P, Morisky D. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol 2004; 19:357-362. (Pubitemid 38916494)
13. Breekveldt-Postma NS, Penning-van Beest FJ, Siiskonen SJ, Koerselman J, Klungel OH, Falvey H, et al. Effect of persistent use of antihypertensives on blood pressure goal attainment. Curr Med Res Opin 2008; 24:1025-1031. (Pubitemid 351579159)
14. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 2002; 40:794-811.
15. Hasford J, Mimran A, Simons WR. A population-based European cohort study of persistence in newly diagnosed hypertensive patients. J Hum Hypertens 2002; 16:569-575. (Pubitemid 35021364)
16. Breekveldt-Postma NS, Penning-van Beest FJA, Sliskonen SJ, Falvey H, Vincze G, Klungel OH, Herings RM. The effect of discontinuation of antihypertensives on the risk of acute myocardial infarction and stroke. Curr Med Res Opin 2008; 24:121-127. (Pubitemid 351160245)
17. Nelson MR, Reid CM, Ryan P, Willson K, Yelland L. Self-reported adherence with medication and cardiovascular disease outcomes in the Second Australian National Blood Pressure Study (ANBP2). Med J Aust 2006; 185:487-489. (Pubitemid 44756209)
18. Mazzaglia G, Ambrosioni E, Alacqua M, Filippi A, Sessa E, Immordino V, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation 2009; 120:1598-1605.
19. Kettani FZ, Dragomir A, Cô té R, Roy L, Bé rard A, Blais L, et al. Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention. Stroke 2009; 40:213-220.
20. Perreault S, Dragomir A, White M, Lalonde L, Blais L, Bé rard A. Better adherence to antihypertensive agents and risk reduction of chronic heart failure. J Intern Med 2009; 266:207-218.
21. Perreault S, Dragomir A, Roy L, White M, Blais L, Lalonde L, Bé rard A. Adherence level of antihypertensive agents in coronary artery disease. Br J Clin Pharmacol 2010; 69:74-84.
22. Hughes D, McGuire A. The direct cost to NHS of discontinuing and switching prescriptions for hypertension. J Human Hypertens 1998; 12:533-537. (Pubitemid 28430222)
23. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005; 43:521-530. (Pubitemid 40847288)
24. Breslow NE, Day NE. Statistical methods in cancer research. Vol. II. The design and analysis of cohort studies. IARC Scientific Publications No. 82. Lyon, France: International Agency for Research on Cancer; 1987.
25. Esteve J, Benhamou E, Raymond L. Statistical methods in cancer research. Vol. IV. Descriptive epidemiology. IARC Scientific Publications No. 128. Lyon, France: International Agency for Research on Cancer; 1994.
26. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001; 23:1296-1310. (Pubitemid 32804122)
27. Leonetti G, Rappelli A, Salvetti A, Scapellato L. Long-term effects of indapamide: final results of a two-year Italian multicenter study in systemic hypertension. Am J Cardiol 1990; 2:67-71.
28. The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342:145-153.
29. Ambrosioni E, Leonetti G, Pessina AC, Rappelli A, Trimarco B, Zanchetti A. Patterns of hypertension management in Italy: results of a pharmacoepidemiological survey on antihypertensive therapy. Scientific Committee of the Italian Pharmacoepidemiological Survey on Antihypertensive Therapy. J Hypertens 2000; 18:1691-1699.
30. Poluzzi E, Strahinja P, Vargiu A, Chaibrando G, Silvani MC, Motola D. Initial treatment of hypertension and adherence to therapy in general practice in Italy. Eur J Clin Pharmacol 2005; 61:603-609. (Pubitemid 41414244)
31. Corrao G, Parodi A, Zambon A, Heiman F, Filippi A, Cricelli C, et al. Reduced discontinuation of antihypertensive treatment by two drug combination as 1st step. Evidence from daily life practice. J Hypertens 2010; 28:1584-1590.
32. Corrao G, Parodi A, Nicotra F, Zambon A, Merlino L, Cesana G, Mancia G. Better compliance to antihypertensive medications reduces cardiovacular risk. J Hypertens 2011; 29:610-618.